| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Immunology | 32 / 243 | 87th | Q1 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Current Research in Immunology
Current Research in Immunology is Scopus-indexed (Q1, CiteScore 12.8). Published by Elsevier B.V..
Checked against the index lists dated .
ISSN 2590-2555Verify ISSN ↗
Publisher: Elsevier B.V.
Cost to publish: About US$2,520 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Current Research in Immunology indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2020–2024, best quartile Q1, CiteScore 12.8.
What quartile is Current Research in Immunology in Scopus?
Current Research in Immunology is Q1 in Immunology (rank 32 of 243), by CiteScore 2025.
What is the impact factor of Current Research in Immunology?
Current Research in Immunology is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 12.8, quartile Q1, 87th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.391, quartile Q1, with an H-index of 19.
How much does it cost to publish in Current Research in Immunology?
The publisher lists an article processing charge of about US$2,520 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Who publishes Current Research in Immunology and what is its ISSN?
Current Research in Immunology is published by Elsevier B.V. Its ISSN is 2590-2555.
Is Current Research in Immunology in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Current Research in Immunology open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
How well cited is Current Research in Immunology? — open metrics via OpenAlex
Current Research in Immunology has an h-index of 23 and a 2-year mean of 6.17 citations per paper (OpenAlex). Its Scopus CiteScore is 12.8, quartile Q1. On 2-year citations it ranks #33 of 240 Scopus journals in Immunology.
Current Research in Immunology published 6 papers in 2024; its busiest recent year was 2021 with 27. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in Current Research in Immunology? — latest 71 articles, 2021–2024
In its latest 71 research articles (2021–2024), authors are most often from United States (19.7%), Brazil (16%) and India (12.7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Current Research in Immunology? — indicators, not proof of misconduct
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.